ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 445,69
2,24%
Dow Jones
42 706,56
-0,06%
DAX
20 216,19
1,54%
Brent Oil
75,995
-0,16%
Bitcoin
101 640,70
-0,63%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. XBiotech Inc (XBIT) Cours

XBiotech Inc

XBiotech Inc (XBIT)

NASDAQ
4,48
0,06
(1,36%)
Fermé 07 Janvier 10:00PM
Retardé de 15 minutes
4,48
0,00
(0,00%)
Après les heures de négociation: 12:00AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
4,48
Prix Achat
4,15
Prix Vente
4,75
Volume échangé
114 145
4,46 Fourchette du Jour 4,67
3,51 Plage de 52 semaines 9,96
Cap du marché
136,566M
Clôture Veille
4,42
Ouverture
4,52
Dernière Transaction
907
@
4.48
(priorref)
Dernière heure de transaction
Volume financier
US$ 518 539
VWAP
4,5428
Volume moyen (3 m)
66 568
Actions en circulation
30 483 481
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,21
Bénéfice par action (BPA)
-1,08
Chiffre d'affairess
4,01M
Bénéfice net
-32,9M

À propos de XBiotech Inc

XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.xbiotech.com
Siège social
Austin, Texas, USA
Fondé
-
XBiotech Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker XBIT. Le dernier cours de clôture d'XBiotech était de US$4,42. Au cours de la dernière année, les actions de XBiotech ont été négociées dans une fourchette de prix de US$ 3,51 à US$ 9,96.

XBiotech compte actuellement 30 483 481 actions en circulation. La capitalisation boursière d'XBiotech est de US$134,74 million. XBiotech a un ratio cours/bénéfice (ratio PE) de -4.21.

XBIT Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

31 Décembre 2024
Edgar (US Regulatory)

XBiotech Pauses Rheumatology program

AUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data that it is halting its clinical program in rheumatological disease while it seeks to understand the...

23 Décembre 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Août 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 Juin 2024
Edgar (US Regulatory)

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...

18 Juin 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

10 Mai 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

07 Février 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

07 Février 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Janvier 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.6717.58530183733.814.543.72783364.13130285CS
4-1.87-29.44881889766.357.243.511025455.31329138CS
12-2.92-39.45945945957.48.323.51665686.25973493CS
26-1.1-19.71326164875.588.323.51618816.46807437CS
520.4310.61728395064.059.963.51785346.52699625CS
156-6.67-59.820627802711.1511.93637856.04495445CS
260-14.16-75.965665236118.6431.85312170013.98104071CS

XBIT - Frequently Asked Questions (FAQ)

What is the current XBiotech share price?
The current share price of XBiotech is US$ 4,48
How many XBiotech shares are in issue?
XBiotech has 30 483 481 shares in issue
What is the market cap of XBiotech?
The market capitalisation of XBiotech is USD 134,74M
What is the 1 year trading range for XBiotech share price?
XBiotech has traded in the range of US$ 3,51 to US$ 9,96 during the past year
What is the PE ratio of XBiotech?
The price to earnings ratio of XBiotech is -4,21
What is the cash to sales ratio of XBiotech?
The cash to sales ratio of XBiotech is 34,52
What is the reporting currency for XBiotech?
XBiotech reports financial results in USD
What is the latest annual turnover for XBiotech?
The latest annual turnover of XBiotech is USD 4,01M
What is the latest annual profit for XBiotech?
The latest annual profit of XBiotech is USD -32,9M
What is the registered address of XBiotech?
The registered address for XBiotech is 5217 WINNEBAGO LN, AUSTIN, TX 78744, AUSTIN, TEXAS, 78744
What is the XBiotech website address?
The website address for XBiotech is www.xbiotech.com
Which industry sector does XBiotech operate in?
XBiotech operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BOXLBoxlight Corporation
US$ 1,645
(257,61%)
240,37M
SPRCSciSparc Ltd
US$ 1,06
(100,80%)
189,16M
XTIAXTI Aerospace Inc
US$ 0,08261
(99,54%)
1,55B
DHAIDIH Holdings US Inc
US$ 2,8602
(82,18%)
4,63M
NXPLNextPlat Corporation
US$ 1,73
(61,68%)
12,6M
RGFReal Good Food Company Inc
US$ 1,31
(-63,49%)
1,47M
LUNALuna Innovations Incorporated
US$ 0,8744
(-57,35%)
12,25M
GCTKGlucoTrack Inc
US$ 0,1594
(-45,65%)
35,5M
ACONAclarion Inc
US$ 0,1699
(-43,06%)
34,75M
BLRXBioLineRx Ltd
US$ 0,1621
(-40,80%)
43,2M
XTIAXTI Aerospace Inc
US$ 0,08261
(99,54%)
1,55B
NVDANVIDIA Corporation
US$ 149,43
(3,43%)
256,78M
CNSPCNS Pharmaceuticals Inc
US$ 0,11987
(-2,54%)
243,9M
BOXLBoxlight Corporation
US$ 1,645
(257,61%)
240,37M
SPRCSciSparc Ltd
US$ 1,06
(100,80%)
189,16M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
XBIT
XBiotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés